Clinical Trials in San Diego

Showing 1561-1580 of 7,028 trials

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

NCT05886894

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix plus HydraGlyde Multifocal soft contact lenses in a real-world setting when worn as daily wear or extended (overnight) wear.

Refractive Errors

Alcon Research351 participantsStarted Aug 2023

San Diego, California, United States • Jacksonville, Florida, United States • Miami, Florida, United States +5 more locations

COMPLETEDPhase 3< 1 mile

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

NCT04513912

The purpose of this study is to assess the efficacy of seltorexant compared with quetiapine extended-release (XR) as adjunctive therapy to an antidepressant drug in treatment response in participants with major depressive disorder with insomnia symptoms (MDDIS) who have had an inadequate response to current antidepressant therapy with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI).

Depressive Disorder, Major

Janssen Research & Development, LLC757 participantsStarted Sep 2020

Birmingham, Alabama, United States • Tucson, Arizona, United States • Culver City, California, United States +172 more locations

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Find Trials by Condition in San Diego

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Assessing and Improving the Durability of Compensatory Cognitive Training for Older Veterans

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

Lupus Landmark Study: A Prospective Registry and Biorepository

Expanded Access of Sotorasib

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Actis Total Hip System 2 Year Follow-up

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours